HSV-2 genital
Selected indexed studies
- Genital Herpes Infection: Progress and Problems. (Infect Dis Clin North Am, 2023) [PMID:37105647]
- HSV-2 Infection of Human Genital Epithelial Cells Upregulates TLR9 Expression Through the SP1/JNK Signaling Pathway. (Front Immunol, 2020) [PMID:32194565]
- The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection. (Am J Reprod Immunol, 2008) [PMID:18154594]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Genital Herpes Infection: Progress and Problems. (2023) pubmed
- HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens. (2022) pubmed
- HSV-2 Infection of Human Genital Epithelial Cells Upregulates TLR9 Expression Through the SP1/JNK Signaling Pathway. (2020) pubmed
- The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection. (2008) pubmed
- HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection. (2013) pubmed
- Genital Herpes Simplex Virus Infections in Women-A Clinical Update. (2025) pubmed
- Genital HSV-1 infections. (2006) pubmed
- Microbial Diversity of Genital Ulcers of HSV-2 Seropositive Women. (2017) pubmed
- Primary oral vaccination followed by a vaginal pull protects mice against genital HSV-2 infection. (2023) pubmed
- NK cell-derived extracellular granzyme B drives epithelial ulceration during HSV-2 genital infection. (2023) pubmed